Format

Send to

Choose Destination
See comment in PubMed Commons below
J Immunol Methods. 2006 May 30;312(1-2):34-9. Epub 2006 Mar 6.

A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.

Author information

1
Brigham Young University, Provo, UT 84602, USA.

Abstract

CD1d presentation of alpha-galactosyl ceramides to natural killer T cells has been a focal point of the study of regulatory T cells. KRN7000, an alpha-galactosyl ceramide originally generated from structure activity studies of antitumor properties of marine sponge glycolipids, is currently the most commonly used agonist ligand and is used to stain NKT cells. However, this glycolipid suffers from poor solubility and availability. We have developed an alpha-galactosyl ceramide with improved solubility over KRN7000 that effectively stains NKT cells, both mouse and human, and stimulates cytokine release at low concentrations.

PMID:
16647712
DOI:
10.1016/j.jim.2006.02.009
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center